Pacira Pharmaceuticals, Inc.'s Phase III Study of EXPAREL(TM) Meets Primary Pain Relief Endpoint
10/20/2009 6:35:58 AM
More...
|
Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Pharmaceuticals, Inc. Complete Enrollment Data from Soft Tissue and Bone Surgery Studies Basis of Planned 2009 NDA Filing
1/6/2009 8:11:34 AM
More...
|
Pacira Pharmaceuticals, Inc. Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) Novel Local Analgesic Results in Sustained Plasma Concentrations Significantly Reducing Postoperative Pain
12/15/2008 8:02:40 AM
More...
|
Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
10/2/2008 8:04:55 AM
More...
|
Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
8/6/2008 7:43:47 AM
More...
|
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
7/9/2008 9:12:14 AM
More...
|
Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
4/15/2008 7:59:21 AM
More...
|
Pacira Pharmaceuticals, Inc. Names New CEO and President
12/19/2007 7:25:37 AM
More...
|
Orphan Australia Pty Ltd Receives Registration Approval for the New Dose Form DepoDur(R), Pacira Pharmaceuticals, Inc.'s Modified Release Injection of Morphine Sulfate
10/22/2007 10:20:57 AM
More...
|
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals, Inc. to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
9/27/2007 12:38:48 PM
More...
|
|